loading...
 This Article 
   
 Share 
   
 Bibliographic References 
   
 Add to: 
 
Digg
Furl
Spurl
Blink
Simpy
Google
Del.icio.us
Y!MyWeb
 
 Search 
   
Third International Conference on Information Technology and Applications (ICITA'05) Volume 1
Comparative Study of Multivariate Classification Methods Using Microarray Gene Expression Data for BRCA1/BRCA2 Cancer Tumors
Sydney, Australia
July 04-July 07
ISBN: 0-7695-2316-1
Mansoor Raza, Monash University
Iqbal Gondal, Monash University
David Green, Monash University
Ross L. Coppel, Monash University
High dimensionality is one the major problem in the classification of microarray gene expression data. Most of the classifiers performed well for the data having same number of features as the number of samples. But gene expression data have very few samples as compare to the number of genes or features. We use Class Prediction (CP) with Compound Covariant Predictor (CCP), Diagonal Linear Discriminant Analysis (DLDA), k-Nearest Neighbor (NN), Nearest Centroid (NC) and Support Vector Machine (SVM) to create multivariate predictor to determine the class of a given data sample. In this paper, CP has been used to classify the tumor groups from the microarrays dataset taken from breast cancer patients. The paper presents comparative results to determine the accuracy of a cancer gene classification based on six multivariate classifiers. Our results have shown that CCP has performed best with an accuracy of 100%, 85% and 86% among three tumor groups. Accurate analysis and classification of gene expression profiles could lead to more reliable tumor classification, better prognostic prediction and selection of more appropriate treatments.
Citation:
Mansoor Raza, Iqbal Gondal, David Green, Ross L. Coppel, "Comparative Study of Multivariate Classification Methods Using Microarray Gene Expression Data for BRCA1/BRCA2 Cancer Tumors," icita, vol. 1, pp.475-480, Third International Conference on Information Technology and Applications (ICITA'05) Volume 1, 2005
Usage of this product signifies your acceptance of the Terms of Use.